Comorbidity and Disease Clustering

Comorbidity and disease clustering concerns the co-occurrence of multiple chronic conditions - within individuals (comorbidity and multimorbidity) and within populations (clustering). Because chronic diseases share risk factors and accumulate with age, they rarely occur in isolation, and their co-occurrence shapes prognosis, complexity of care, and the structure of health burden.

Definition

The study of the co-occurrence of two or more distinct chronic conditions - either relative to an index disease (comorbidity) or as the simultaneous presence of multiple conditions without an index (multimorbidity) - and of the non-random clustering of diseases across populations.

Scope

The entry covers the definitions and distinctions among comorbidity, multimorbidity, and clustering; how co-occurrence is measured and indexed; its descriptive epidemiology; and its consequences for outcomes and care. It is a cross-cutting reference topic, not clinical guidance for managing individual patients.

Core questions

• How are comorbidity, multimorbidity, and clustering defined and distinguished?
• How common is multimorbidity, and how does it vary with age and deprivation?
• How is the burden of co-occurring conditions measured and summarised?

Key concepts

• Comorbidity versus multimorbidity
• Index condition
• Disease clustering (non-random co-occurrence)
• Comorbidity indices (e.g. Charlson index)
• Shared risk factors
• Socioeconomic gradient in multimorbidity
• Treatment burden and care complexity

Mechanisms

Conditions co-occur for several reasons: they may share upstream risk factors (so a common exposure raises the probability of several diseases); one disease may causally precipitate another; or detection of one condition may increase the chance of diagnosing others. Distinguishing these pathways matters because clustering can be a marker of shared causation rather than direct disease-to-disease links (Valderas et al., 2009; Feinstein, 1970). Aggregating co-occurring conditions into indices, such as the Charlson comorbidity index, allows their joint effect on prognosis to be summarised and adjusted for in analysis (Charlson et al., 1987).

Clinical relevance

Comorbidity shapes prognosis, complicates the application of single-disease guidelines, and increases treatment burden, making it central to the organisation of care for people with several conditions. This entry describes how co-occurrence is conceptualised and measured in epidemiology and health-services research; it does not offer recommendations for managing individual patients.

Epidemiology

Multimorbidity is common and rises steeply with age, but in absolute terms many people living with multiple conditions are below age 65, and onset occurs earlier in more deprived populations - a marked socioeconomic gradient (Barnett et al., 2012). Mental-health conditions frequently co-occur with physical chronic disease, and the prevalence of multimorbidity is high enough that, in many health systems, the typical patient with a chronic disease has at least one additional condition (Barnett et al., 2012).

Evidence & guidelines

The conceptual framework distinguishing comorbidity from multimorbidity and from clustering is set out in methodological reviews (Valderas et al., 2009; Feinstein, 1970). Large primary-care studies provide the descriptive epidemiology, including the age and deprivation gradients (Barnett et al., 2012), and validated indices provide standardised measurement of comorbidity burden (Charlson et al., 1987).

History

The term 'comorbidity' was introduced by Alvan Feinstein in 1970 to describe additional conditions present alongside an index disease in clinical studies (Feinstein, 1970). The Charlson index (1987) gave researchers a standardised way to quantify comorbid burden for prognosis (Charlson et al., 1987). As single-disease models proved inadequate for ageing, multi-condition populations, the broader concept of multimorbidity gained prominence, crystallised by large cross-sectional studies showing its scale and social patterning (Valderas et al., 2009; Barnett et al., 2012).

Debates

Comorbidity versus multimorbidity as the right frame

An index-disease ('comorbidity') view fits single-disease research and guidelines but can obscure the experience of patients with several equally important conditions, for whom a non-hierarchical 'multimorbidity' frame may better reflect need; which frame to adopt depends on the question and remains contested.

Key figures

• Alvan R. Feinstein
• Jose M. Valderas
• Barbara Starfield
• Mary Charlson

Seminal works

• feinstein-1970
• valderas-2009
• barnett-2012
• charlson-1987

Frequently asked questions

What is the difference between comorbidity and multimorbidity?

Comorbidity describes additional conditions relative to a specific index disease, whereas multimorbidity describes the presence of multiple chronic conditions without privileging any one of them as the main condition.

Is multimorbidity only a problem of old age?

It becomes more prevalent with age, but because younger age groups are larger, many people with multimorbidity are under 65, and onset tends to be earlier in socioeconomically deprived populations.